Cancer biopsy
Conditions
Interventions
Control Group 1:Participants will undergo CT-guided percutaneous biopsy.
Control Group 2:Participants will undergo CT-guided percutaneous biopsy with the assistance of a puncture navigation positioning system.
Experimental Group:Participants will undergo 18F-FDG PET/CT-guided percutaneous biopsy with the assistance of a puncture navigation positioning system.
Sponsors
Subei People’s Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. Age 18-90 years (inclusive), no gender restriction. 2. Clinically diagnosed with suspected malignant tumor lesions requiring further biopsy confirmation. 3. Good patient compliance, able to complete percutaneous biopsy and other study requirements. 4. Voluntarily participate in the clinical trial and sign the informed consent form. 5. For the PET/CT-guided puncture group, patients must have one or more high-uptake lesions shown on PET/CT.
Exclusion criteria
Exclusion criteria: 1. Uncorrectable coagulation disorders or undergoing anticoagulant therapy. 2. Tendency to bleed. 3. Pregnant or lactating women. 4. Positive results in four infectious disease tests, combined with other clinical manifestations, as judged by the researcher. 5. Patients deemed unsuitable for inclusion by the researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of CT Scans During Procedure;Success Rate of Obtaining Pathological Tissue; | — |
Secondary
| Measure | Time frame |
|---|---|
| Positive Rate of Obtained Biopsy Tissue;Success Rate of Positioning with =2 Adjustments;Success Rate of Positioning with =1 Adjustment;Radiation Dose Received by Participants During CT Scans;Duration of Biopsy Procedure;Quality of Pathological Specimens;Radiation Dose Received by Operators; | — |
Countries
China
Contacts
Public ContactXia Lu
Department of Nuclear Medicine, Subei People’s Hospital
Outcome results
None listed